Cipla Ltd. (CIPL)

1,124.90
-14.75(-1.29%)
  • वॉल्यूम:
    1,360,338
  • बोली/पुछे:
    0.00/0.00
  • दिन की रेंज:
    1,117.00 - 1,145.20

CIPL समीक्षा

पिछला बंद
1,139.65
दिन की रेंज
1,117-1,145.2
आय
222.02B
खुला
1,145
52 सप्ताह रेंज
850-1,185.25
ईपीएस
31.8
वॉल्यूम
1,360,338
मार्केट कैप
908.37B
लाभांश (यील्ड)
5.00
(0.44%)
औसत वॉल्यूम (3एम)
1,682,820
पी/ई अनुपात
35.60
बीटा
0.358
1- वर्ष बदलाव
17.67%
बकाया शेयर
807,049,497
अगली कमाई तिथि
07 फ़र॰ 2023
सिप्ला पर आपकी भावना क्या है?
या
अभी बाज़ार बंद हैं। वोटिंग बाजार का समय के दौरान खुली है।

सिप्ला समाचार

सिप्ला विश्लेषण

सिप्ला कंपनी प्रोफाइल

सिप्ला कंपनी प्रोफाइल

कर्मचारी
25927
बाज़ार
भारत
  • प्रकार:इक्विटी
  • बाज़ार:भारत
  • आईसआईन:INE059A01026
  • एस/न:CIPLA

Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry. It also provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Cipla Limited has a licensing agreement with Merck & Co., Inc. for the manufacturing and distribution of Molnupiravir, an investigational oral antiviral drug; a license agreement with Eli Lilly and Company for the manufacture and commercialization of the drug baricitinib for Covid-19 indication; and collaborations with Dr. Reddy’s Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for the clinical trial of the investigational oral anti-viral drug Molnupiravir. The company was incorporated in 1935 and is headquartered in Mumbai, India.

और पढ़ें

तकनीकी सारांश

प्रकार
5 मिनट
15 मिनट
प्रति घंटा
दैनिक
मासिक
मूविंग एवरेजखरीदेंमजबूत खरीदमजबूत खरीदमजबूत खरीदमजबूत खरीद
तकनीकी संकेतकमजबूत खरीदमजबूत खरीदबेचनामजबूत खरीदमजबूत खरीद
सारांशमजबूत खरीदमजबूत खरीदतटस्थमजबूत खरीदमजबूत खरीद
  • Hdfc+RIL=cipla
    0
    • yes
      0
      • seelling Tisco?
        0
        • not buy at all.
          0
          • see for 914
            0
            • sell cipla for 914
              0
              • 941breakdn comming up.
                0
                • sell with closing stop loss 950tgt 926
                  0
                  • sell with closing stop loss 950tgt 926
                    0
                    • sell with closing stop loss 950tgt 926
                      0